The latest headlines across every section, pulled from official and open-access sources.
Apnimed is having sweet dreams of an IPO that could fund the planned commercial launch of an obstructive sleep apnea therapy that is currently awaiting an FDA approval decision.
Source: Department of Health and Human Services Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: American College of Physicians Related MedlinePlus Pages: Health Occupations
Source: Nemours Foundation Related MedlinePlus Pages: Health Occupations
Source: American Orthopaedic Foot and Ankle Society Related MedlinePlus Pages: Foot Injuries and Disorders
Source: American College of Foot and Ankle Surgeons - PDF Related MedlinePlus Pages: Ankle Injuries and Disorders , Foot Injuries and Disorders
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
The NHS is urging millions of people in their 50s to complete lifesaving bowel cancer screening tests, as new figures show this age group is less likely to take part. The latest annual bowel screening figures show that just over half (56.2%) of 54-year-olds took part in screening in the year April 2024 to March […]
Handspring raised $19 million in Series B funding this week to expand its pediatric mental health care model nationwide. The company treats the full spectrum of acuity so children are matched to the level of care they actually need, rather than defaulting to the most intensive — and expensive — option available. The post Handspring Snags $19M to Fix the “Missing Middle” of Youth Mental Health Care appeared first on MedCity News .
UnitedHealthcare introduced a Lifestyle Spending Account that gives employers more flexibility to fund employees’ health and wellness expenses. The post UHC Unveils New Employer-Sponsored Spending Account Benefit appeared first on MedCity News .
ANDAs: Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions
A Bausch + Lomb drug from a 2025 acquisition missed primary and secondary goals of a Phase 2 test in glaucoma. Bausch now plans to develop this drug for geographic atrophy, aiming to succeed where Allergan, now an AbbVie subsidiary, fell short in the clinic. The post Glaucoma Drug Fails Trial, But Bausch + Lomb Sees Opportunity in Another Eye Disease appeared first on MedCity News .
CDER proposes to withdraw approval of TAVNEOS
ACP expressed its concerns with the proposed changes to the Office of Management and Budget and urged the agency to revise the proposed rule.